The store will not work correctly when cookies are disabled.
(E/Z)-3-((1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)chroman-4-one
ID: ALA4637288
PubChem CID: 156012547
Max Phase: Preclinical
Molecular Formula: C17H12N2O2
Molecular Weight: 276.30
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1C(=Cc2c[nH]c3ncccc23)COc2ccccc21
Standard InChI: InChI=1S/C17H12N2O2/c20-16-12(10-21-15-6-2-1-4-14(15)16)8-11-9-19-17-13(11)5-3-7-18-17/h1-9H,10H2,(H,18,19)
Standard InChI Key: YUOUFOGLFAEVKV-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 24 0 0 0 0 0 0 0 0999 V2000
1.1213 -13.3745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1201 -14.1936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8278 -14.6023 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8260 -12.9659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5342 -13.3709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5344 -14.1936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3170 -14.4477 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8004 -13.7819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3166 -13.1165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5687 -12.3397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3675 -12.1697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9115 -12.7808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7073 -12.6134 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6155 -11.3958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4176 -11.2287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9634 -11.8387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7625 -11.6704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0169 -10.8927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4660 -10.2831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6690 -10.4545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0691 -10.7888 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
9 10 1 0
10 11 2 3
11 12 1 0
11 14 1 0
12 13 1 0
13 16 1 0
15 14 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
14 21 2 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 276.30 | Molecular Weight (Monoisotopic): 276.0899 | AlogP: 3.22 | #Rotatable Bonds: 1 |
Polar Surface Area: 54.98 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.28 | CX LogP: 2.61 | CX LogD: 2.61 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.69 | Np Likeness Score: -0.37 |
References
1. Qhobosheane MA, Legoabe LJ, Josselin B, Bach S, Ruchaud S, Petzer JP, Beteck RM.. (2020) Synthesis and evaluation of 7-azaindole derivatives bearing benzocycloalkanone motifs as protein kinase inhibitors., 28 (11): [PMID:32284225] [10.1016/j.bmc.2020.115468] |